2609 — Bayzed Health Cashflow Statement
0.000.00%
Last trade - 00:00- HK$7.00bn
- HK$7.03bn
- CNY1.12bn
Annual cashflow statement for Bayzed Health, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -62.5 | -4.61 | 13.3 | — |
| Depreciation | ||||
| Non-Cash Items | 24 | 27.5 | 22.3 | — |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | 78.4 | 19.2 | 45.5 | 222 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | 114 | 128 | 169 | 222 |
| Capital Expenditures | -36.4 | -53.8 | -46.5 | -37.9 |
| Purchase of Fixed Assets | ||||
| Purchase / Acquisition of Intangibles | ||||
| Other Investing Cash Flow Items | -172 | -4.8 | 98.6 | -129 |
| Acquisition of Business | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -209 | -58.6 | 52.2 | -167 |
| Financing Cash Flow Items | -111 | -89.5 | -9.02 | -57.4 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 53.4 | 47 | -168 | 268 |
| Foreign Exchange Effects | ||||
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -40.9 | 117 | 52.2 | 322 |